NK
Highly rated in
14
conditions
Highly rated in
14
conditions
Check Dr. Nancy L. Kuntz's experience treating your condition:
About Dr. Nancy L. Kuntz

Nancy Kuntz is a Pediatrics specialist and a Neurologist in Chicago, Illinois. Kuntz has been practicing medicine for over 48 years and is highly rated in 14 conditions, according to our data. Her top areas of expertise are Tubular Aggregate Myopathy, Congenital Fiber-Type Disproportion, X-Linked Myotubular Myopathy, and Spinal Muscular Atrophy (SMA). She is licensed to treat patients in Minnesota. Kuntz is currently accepting new patients.

Her clinical research consists of co-authoring 73 peer reviewed articles and participating in 18 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Nancy L. Kuntz it is best to call her office and ask if your insurance is accepted.


Dr. Nancy L. Kuntz accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter

Call to see if your plan is accepted.
Locations
225 E Chicago Ave, Box 51, Chicago, IL 60611
Background & Education
Graduate Institution
Boston University School Of Medicine, 1975
Specialties
Pediatrics
Neurology
Licenses
Neurology with Special Qualifications in Neurology in MN
Hospital Affiliations
Northwestern Memorial Hospital
Ann & Robert H Lurie Childrens Hospital Of Chicago
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


18 Clinical Trials

A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
A Phase 3b Study to Evaluate Higher Dose Nusinersen (BIIB058) in Patients With Spinal Muscular Atrophy Previously Treated With Risdiplam
Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
The RECENSUS Study: A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)
Phase I, Open-Label, Dose Comparison Study of AVXS-101 for Sitting But Non-ambulatory Patients With Spinal Muscular Atrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
View 14 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors